MedPath
HSA Approval

XPREZA 100 INJECTION 100 MG/VIAL

SIN15118P

XPREZA 100 INJECTION 100 MG/VIAL

XPREZA 100 INJECTION 100 MG/VIAL

November 23, 2016

NATCO PHARMA ASIA PTE. LTD.

NATCO PHARMA ASIA PTE. LTD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantNATCO PHARMA ASIA PTE. LTD.
Licence HolderNATCO PHARMA ASIA PTE. LTD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

INJECTION

SUBCUTANEOUS

Medical Information

L01BC07

azacitidine

Manufacturer Information

NATCO PHARMA ASIA PTE. LTD.

Natco Pharma Limited

Panacea Biotec Pharma Ltd.

Active Ingredients

Azacitidine

100mg

Azacitidine

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.